Suzetrigine as a novel treatment for headache disorders: A case series - PubMed
3 hours ago
- #suzetrigine
- #refractory headache
- #case series
- Suzetrigine is a selective voltage-gated sodium channel blocker recently FDA-approved for acute pain.
- A retrospective evaluation in an academic headache center showed efficacy and tolerability in refractory headache disorders including chronic migraine and trigeminal autonomic cephalalgias.
- Treatment was generally well-tolerated, with most patients reporting improvement based on global impression of change.
- Suzetrigine represents a promising new therapeutic approach warranting further study for headache disorders.